Multistate Lawsuit Against Trump Administration Over Vaccine Schedule
Analysis based on 7 articles · First reported Feb 24, 2026 · Last updated Feb 25, 2026
The lawsuit against the United States===United States Department of Health and Human Services over vaccine schedule changes could create uncertainty in the healthcare and pharmaceutical sectors, potentially affecting public health initiatives and vaccine manufacturers. The legal challenge highlights regulatory risks and potential shifts in public health policy, which could influence investment decisions in related industries.
Two Democratic state attorneys general, led by United States===California and United States===Arizona, announced a multistate lawsuit against the Trump administration over recent changes to the federal government's childhood vaccine schedule. U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has upended longstanding vaccine policies, leading the United States===Centers for Disease Control and Prevention to issue a new immunization schedule that removed universal recommendations for several vaccines. The lawsuit, filed in a Northern United States===California federal court, challenges these changes and Robert F. Kennedy Jr.'s replacement of members on the CDC's Advisory Committee on Immunization Practices. Fourteen states, including United States===Connecticut, United States===Michigan, United States===New Jersey, United States===Pennsylvania, and United States===Wisconsin, are participating. Medical organizations, such as the American Academy of Pediatrics, warn that these changes could lower inoculation rates and have already filed a similar legal action. United States===California AG Rob Bonta stated that United States===California will be forced to expend resources to treat once-rare diseases and combat misinformation.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard